Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 261, Issue 1-2, Pages 67-76Publisher
ELSEVIER
DOI: 10.1016/j.jneuroim.2013.05.006
Keywords
Experimental autoimmune encephalomyelitis (EAE); Glutamate receptors antagonists; Cytokines; Inflammation
Categories
Funding
- Polish Ministry of Science and Higher Education [NN401 620038]
Ask authors/readers for more resources
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Inflammatory cytokines and glutamate neurotoxicity have been proposed as major determinants accompanying the demyelination and axonal degeneration observed during the course of MS. The present study using the animal model of MS known as experimental autoimmune encephalomyelitis (EAE) demonstrates that pharmacological inhibition of ionotropic NMDA glutamate receptors by their antagonists (amantadine and memantine) suppresses neurological symptoms of disease in EAE rats and reduces expression of pro-inflammatory cytokines in the brain. Conversely, antagonists of group I metabotropic glutamate receptors, mGluRs (LY 367385 and MPEP), do not affect the inflammatory process and the neurological condition of EAE rats. (C) 2013 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available